Hills has announced the appointment of David Clarke as Chief Executive Officer with immediate effect.
Mr Clarke brings significant experience as a chief executive officer and chief financial officer of ASX-listed companies, with extensive knowledge across technology and healthcare, as well as distribution and technical field services.
“I am delighted that we have appointed an executive of David’s calibre, with such a strong record in strategic, financial and operational leadership,” said Hills Chairman Jennifer Hill-Ling.
“David’s experience and business skills provide Hills with significant capability to deliver on the Health division’s growth strategy and return the Distribution division to sustained profitability.”
Mr Clarke spent seven years as a senior executive at ASX-listed health software provider Corum Group Limited, including four as CEO and has held executive leadership roles at companies including Medtronic Australasia, Fisher & Paykel and the ASX-listed Nick Scali Limited.
Drawing on past experience in both distribution and health software technologies, Mr Clarke is keen to explore new opportunities with Hills in order to grow the business.
“I’m excited to be taking on this leadership role at Hills,” said Mr Clarke. “I look forward to working with the Board and the entire Hills team, supporting the success of our customers and suppliers, and generating growth that provides a sustainable return for our shareholders.”
Mr Clarke will work with the departing CEO, David Lenz, to ensure a seamless transition until Mr Lenz’s retirement on 1 July 2021. The Hills Board thanked Mr Lenz for his dedication to Hills over the past six years and wished him well in his retirement.
